ASML is the only company on Earth capable of producing EUV lithography systems, creating the most durable monopoly in the semiconductor value chain. Q1 2026 confirmed the AI capex supercycle: €8.8B revenue beat consensus, FY2026 guidance raised to €36-40B, and China headwinds are normalizing FASTER than feared (19% of system sales in Q1 vs 36% in Q4 2025). The variant perception is that installed base management (€2.5B/quarter run rate, +25% YoY) is being mis-valued as cyclical when it is in fact a high-margin compounding annuity, and that the MATCH Act risk (still in committee) is overweighted given ASML's €38.8B backlog cushion and Netherlands/Japan 150-day negotiation window.
| Scenario | Prob. | Target | Driver |
|---|---|---|---|
| Bull | 30% | $1,953.00 | FY2026 revenue lands at high end (€40B); Q2-Q4 bookings sustain >€8B/quarter |
| Base | 45% | $1,519.00 | ASML achieves midpoint of raised FY2026 guidance (~€38B revenue, 52% GM) |
| Bear | 25% | $1,012.00 | MATCH Act passes Senate + signed before Q4 2026 — eliminates remaining China DUV sales AND service revenue (most damaging is the service ban) |
Research-update price re-anchor (manual batch) — ASML +12.1% to $1,784.94 since prior $1,592 anchor; FRESH+CURRENT full re-rate, 2026-06-26
Research-update (manual) — ASML record European market cap + Musk TeraFab direct-talks confirmation, 2026-06-08
Phase B — competitive deep dive refresh + conviction scoring + comps build + monitoring tier upgrade
Full pipeline refresh — Q1 2026 earnings + raised guidance + MATCH Act committee passage + TSMC High-NA confirmed deferral + stock +15% since prior research
Research-update from — MATCH Act export-control proposal + Trump-Xi summit May 14-15 binary regulatory window; -3.54% on 2026-05-12
Financials, thesis, EDGAR validation, competitive deep dive, investment memo, red team analysis
Positioning skews toward near-term upside